The company leverages its proprietary QuEEN discovery engine to enable target-centric MGD discovery and rational design of product candidates. Monte Rosa has established collaborations with major pharma partners including Novartis (with $120M upfront and up to $5.7B total deal value) and has secured $396.2M in cash as of Q3 2025.
Cyborg Score Rationale
MRT-2359 recently demonstrated 100% PSA and disease control rates in AR-mutant mCRPC Phase 1/2 data, indicating strong clinical efficacy. With $396.2M in cash and runway through 2028, plus a major Novartis collaboration generating meaningful revenue, the company has strong capital position and multiple clinical catalysts ahead including MRT-8102 Phase 1 readout in H1 2026.
Top Insights
Recent Phase 1/2 data for lead oncology candidate MRT-2359 showed 100% PSA response and disease control rates in AR-mutant metastatic castration-resistant prostate cancer
Novartis collaboration with $120M upfront and up to $5.7B in total deal value provides strong validation and revenue diversification
$396.2M in cash with runway through 2028 and multiple clinical readouts expected (MRT-8102 H1 2026, MRT-6160 Phase 2, updated MRT-2359 data by year-end 2025)
Broad pipeline spanning oncology, immunology, inflammation, cardiovascular, metabolic and genetic diseases provides multiple value inflection opportunities
Named Competitors
Protein Degradation Platform — PROTAC-based protein degradation
Protein Degradation Platform — Targeted protein degradation therapies
Protein Degradation Platform — E3 ligase-based protein degradation
Protein Degradation Platform — Protein degradation and epigenetics
Recent Developments
(February 2026) MRT-2359 demonstrates 100% PSA and disease control rates in AR-mutant mCRPC Phase 1/2 data
(Q3 2025) Novartis collaboration announced with $120M upfront and up to $5.7B total deal value; cash position $396.2M
(H1 2026) MRT-8102 Phase 1 initial readout expected on track
Open the full interactive Monte Rosa Therapeutics, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.